Dr. Nasrallah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 617-726-2000Fax+1 617-726-4803
Education & Training
Massachusetts General HospitalFellowship, Rheumatology, 2016 - 2019
Cleveland Clinic FoundationResidency, Internal Medicine, 2013 - 2016
University of Jordan Faculty of MedicineClass of 2010
Certifications & Licensure
MA State Medical License 2016 - 2026
ME State Medical License 2021 - 2022
OH State Medical License 2013 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 14 citationsEffect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer.Leyre Zubiri, Gabriel E. Molina, Meghan J. Mooradian, Justine V. Cohen, Sienna Durbin
Journal for Immunotherapy of Cancer. 2021-09-01 - 23 citationsPredictors of rheumatic immune-related adverse events and de novo inflammatory arthritis after immune checkpoint inhibitor treatment for cancerAmy Cunningham-Bussel, Jiaqi Wang, Lauren C. Prisco, Lily W Martin, Kathleen M M Vanni
Arthritis & Rheumatology. 2021-08-16 - 23 citationsTemporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018Gabriel E. Molina, Leyre Zubiri, Justine V. Cohen, Sienna Durbin, Laura A. Petrillo
The Oncologist. 2021-06-01
Press Mentions
The 2019 ACR Award Winners & Distinguished FellowsDecember 18th, 2019
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
